This trial will test if improving the speed, coordination, and accuracy of the less-impaired arm can improve functional independence for people with chronic stroke.
8 Primary · 6 Secondary · Reporting Duration: within 1 week following last treatment session
2 Treatment Groups
Less-Impaired Arm Training
1 of 2
Contralesional Arm Comparison
1 of 2
60 Total Participants · 2 Treatment Groups
Primary Treatment: Less-Impaired Arm Training · Has Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 85 · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
- Maenza, Candice, Robert L. Sainburg, Rini Varghese, Brooke Dexheimer, Marika Demers, Lauri Bishop, Shanie A. L. Jayasinghe, David A. Wagstaff, Carolee Winstein, and For the IPSI Investigative Team. 2022. “Ipsilesional Arm Training in Severe Stroke to Improve Functional Independence (IPSI): Phase II Protocol”. BMC Neurology. Springer Science and Business Media LLC. doi:10.1186/s12883-022-02643-z.
- Robert L. Sainburg 2019. "Predicting Ipsilesional Motor Deficits in Stroke With Dynamic Dominance Model". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03634397.
Frequently Asked Questions
How many participants are being enrolled in this medical trial?
"Affirmative. According to clinicaltrials.gov, this research project which was initially shared on February 2nd 2019 is actively searching for test subjects. A total of 120 individuals must be gathered from two distinct medical centres in order to continue the trial." - Anonymous Online Contributor
Is enrollment open for this trial at present?
"According to clinicaltrials.gov, this scientific study is currently inviting participants. The investigation was initially published on February 2nd 2019 and most recently revised on September 28th 2022." - Anonymous Online Contributor
What criteria must be met to qualify for participation in this clinical trial?
"This medical trial is enrolling 120 individuals, aged 18-85 with confirmed unilateral brain damage caused by a stroke. To be eligible for the study, participants must also possess preserved cognitive faculties and demonstrate contralesional upper limb weakness as assessed by JTHFT in addition to being 6+ months post-stroke." - Anonymous Online Contributor
What are the key aims of this clinical experiment?
"This trial's primary purpose is to assess the impact of treatment on Upper-Extremity Fugl-Meyer Assessment through two pre-treatment tests (1 week apart) and three post tests: 1 following last session, 2 weeks after intervention completion, and 6 months later. Secondary objectives include evaluating FIM motor subscale for self care activities burden; position variability early/late in movement; kinematic variability during reaching movements." - Anonymous Online Contributor
Are participants aged below sixty years of age admissible for this trial?
"This investigation is accepting applicants older than 18 years and younger than 85 years." - Anonymous Online Contributor